phrykt

Idexx Laboratories (IDXX) debt: $450M

Idexx Laboratories had $450M of long-term debt on Dec 31, 2025, including the part due within a year, down 27.2% from $618M a year earlier.

From Idexx Laboratories's filings with the SEC · Read the filing · IDXX stock page

Idexx Laboratories debt by year

$851M2021$770M2022$698M2023$618M2024$450M2025

#1,160 of 2,129 US companies by debt · See the full ranking

Year endedDebtChange
Dec 31, 2025$450M-27%
Dec 31, 2024$618M-12%
Dec 31, 2023$698M-9%
Dec 31, 2022$770M-10%
Dec 31, 2021$851M–

Debt of similar companies

Companies in the same industry as Idexx Laboratories, by SEC industry code, with the closest debt. Each name opens the same page for that company.

CompanyDebt, latest yearYear ended
Curaleaf Holdings$549MDec 31, 2025
INSMED$547MDec 31, 2025
Repligen$542MDec 31, 2025
Idexx Laboratories$450MDec 31, 2025
Pacira BioSciences$372MDec 31, 2025
Mannkind$355MDec 31, 2025
Opko Health$344MDec 31, 2025

Questions and answers

What is Idexx Laboratories's debt?

Idexx Laboratories had $450M of long-term debt on Dec 31, 2025, including the part due within a year, down 27.2% from $618M a year earlier.

Numbers as reported in Idexx Laboratories's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology